Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Antiandrogen Treatment (EAT) With Dutasteride for COVID-19 (EAT-DUTA AndroCoV Trial)

NCT04729491 is registered in ClinicalTrials.gov with Corpometria Institute as lead sponsor.

NCT NCT04729491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04729491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Antiandrogen Treatment (EAT) With Dutasteride for COVID-19 (EAT-DUTA AndroCoV Trial)
Lead sponsor
Corpometria Institute
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2020
Completion date
October 7, 2020
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19